• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗补助基于价值的支付与精神疾病患者的医疗保健使用。

Medicaid Value-Based Payments and Health Care Use for Patients With Mental Illness.

机构信息

Department of Population Health, NYU Grossman School of Medicine, New York, New York.

Division of Healthcare Delivery Science, Department of Population Health, NYU School of Medicine, New York, New York.

出版信息

JAMA Health Forum. 2023 Sep 1;4(9):e233197. doi: 10.1001/jamahealthforum.2023.3197.

DOI:10.1001/jamahealthforum.2023.3197
PMID:37738064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10517380/
Abstract

IMPORTANCE

Medicaid patients with mental illness comprise one of the most high-need and complex patient populations. Value-based reforms aim to improve care, but their efficacy in the Medicaid program is unclear.

OBJECTIVE

To investigate if New York state's Medicaid value-based payment reform was associated with improved utilization patterns for patients with mental illness.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used a difference-in-differences analysis to compare changes in utilization between Medicaid beneficiaries whose outpatient practices participated in value-based payment reform and beneficiaries whose practices did not participate from before (July 1, 2013-June 30, 2015) to after reform (July 1, 2015-June 30, 2019). Participants were Medicaid beneficiaries in New York state aged 18 to 64 years with major depression disorder, bipolar disorder, and/or schizophrenia. Data analysis was performed from April 2021 to July 2023.

EXPOSURE

Beneficiaries were exposed to value-based payment reforms if their attributed outpatient practice participated in value-based payment reform at baseline (July 1, 2015).

MAIN OUTCOMES AND MEASURES

Primary outcomes were the number of outpatient primary care visits and the number of behavioral health visits per year. Secondary outcomes were the number of mental health emergency department visits and hospitalizations per year.

RESULTS

The analytic population comprised 306 290 individuals with depression (67.4% female; mean [SD] age, 38.6 [11.9] years), 85 105 patients with bipolar disorder (59.6% female; mean [SD] age, 38.0 [11.6] years), and 71 299 patients with schizophrenia (45.1% female; mean [SD] age, 40.3 [12.2] years). After adjustment, analyses estimated a statistically significant, positive association between value-based payments and behavioral health visits for patients with depression (0.91 visits; 95% CI, 0.51-1.30) and bipolar disorder (1.01 visits; 95% CI, 0.22-1.79). There was no statistically significant changes to primary care visits for patients with depression and bipolar disorder, but value-based payments were associated with reductions in primary care visits for patients with schizophrenia (-1.31 visits; 95% CI, -2.51 to -0.12). In every diagnostic population, value-based payment was associated with significant reductions in mental health emergency department visits (population with depression: -0.01 visits [95% CI, -0.02 to -0.002]; population with bipolar disorder: -0.02 visits [95% CI, -0.05 to -0.001]; population with schizophrenia: -0.04 visits [95% CI, -0.07 to -0.01]).

CONCLUSIONS AND RELEVANCE

In this cohort study, Medicaid value-based payment reform was statistically significantly associated with an increase in behavioral health visits and a reduction in mental health emergency department visits for patients with mental illness. Medicaid value-based payment may be effective at altering health care utilization in patients with mental illness.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c1/10517380/1cf869770726/jamahealthforum-e233197-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c1/10517380/8c272b63876f/jamahealthforum-e233197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c1/10517380/1cf869770726/jamahealthforum-e233197-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c1/10517380/8c272b63876f/jamahealthforum-e233197-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0c1/10517380/1cf869770726/jamahealthforum-e233197-g002.jpg
摘要

重要性

患有精神疾病的医疗补助患者是需求最高和最复杂的患者群体之一。基于价值的改革旨在改善护理,但它们在医疗补助计划中的效果尚不清楚。

目的

调查纽约州的医疗补助基于价值的支付改革是否与精神疾病患者的利用模式改善相关。

设计、设置和参与者:这项回顾性队列研究使用差异中的差异分析,比较了在门诊实践参与基于价值的支付改革的医疗补助受益人和未参与实践的受益人(2013 年 7 月 1 日至 2015 年 6 月 30 日)在改革后(2015 年 7 月 1 日至 2019 年 6 月 30 日)的利用变化。参与者是纽约州年龄在 18 至 64 岁之间的患有重度抑郁症、双相情感障碍和/或精神分裂症的医疗补助受益人。数据分析于 2021 年 4 月至 2023 年 7 月进行。

暴露

如果受益人的归因门诊实践在基线时(2015 年 7 月 1 日)参与基于价值的支付改革,则他们将面临基于价值的支付改革。

主要结果和测量

主要结果是每年的门诊初级保健就诊次数和行为健康就诊次数。次要结果是每年的心理健康急诊就诊次数和住院次数。

结果

分析人群包括 306290 名患有抑郁症的个体(67.4%为女性;平均[SD]年龄,38.6[11.9]岁)、85105 名患有双相情感障碍的患者(59.6%为女性;平均[SD]年龄,38.0[11.6]岁)和 71299 名患有精神分裂症的患者(45.1%为女性;平均[SD]年龄,40.3[12.2]岁)。调整后分析估计,基于价值的支付与抑郁症患者(0.91 次就诊;95%CI,0.51-1.30)和双相情感障碍患者(1.01 次就诊;95%CI,0.22-1.79)的行为健康就诊之间存在统计学上显著的正相关。抑郁症和双相情感障碍患者的初级保健就诊次数没有统计学上的显著变化,但基于价值的支付与精神分裂症患者的初级保健就诊次数减少有关(-1.31 次就诊;95%CI,-2.51 至-0.12)。在每个诊断人群中,基于价值的支付与心理健康急诊就诊次数的显著减少相关(抑郁症人群:-0.01 次就诊[95%CI,-0.02 至-0.002];双相情感障碍人群:-0.02 次就诊[95%CI,-0.05 至-0.001];精神分裂症人群:-0.04 次就诊[95%CI,-0.07 至-0.01])。

结论和相关性

在这项队列研究中,医疗补助基于价值的支付改革与精神疾病患者的行为健康就诊次数增加和心理健康急诊就诊次数减少有统计学上的显著关联。基于价值的医疗补助支付可能在改变精神疾病患者的医疗保健利用方面是有效的。

相似文献

1
Medicaid Value-Based Payments and Health Care Use for Patients With Mental Illness.医疗补助基于价值的支付与精神疾病患者的医疗保健使用。
JAMA Health Forum. 2023 Sep 1;4(9):e233197. doi: 10.1001/jamahealthforum.2023.3197.
2
Assessment of Behavioral Health Services Use Among Low-Income Medicare Beneficiaries After Reductions in Coinsurance Fees.评估低收入医疗保险受益人的行为健康服务使用情况在降低共付费用后。
JAMA Netw Open. 2020 Oct 1;3(10):e2019854. doi: 10.1001/jamanetworkopen.2020.19854.
3
Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.参与肿瘤治疗模式与医疗保险支付、利用、医疗服务提供和质量结果的关联。
JAMA. 2021 Nov 9;326(18):1829-1839. doi: 10.1001/jama.2021.17642.
4
Use of Telemedicine and Quality of Care Among Medicare Enrollees With Serious Mental Illness.使用远程医疗和严重精神疾病的医疗保险参保者的医疗质量。
JAMA Health Forum. 2023 Oct 6;4(10):e233648. doi: 10.1001/jamahealthforum.2023.3648.
5
Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic.COVID-19 大流行期间严重精神疾病的 Medicare 受益人的护理中断。
JAMA Netw Open. 2022 Jan 4;5(1):e2145677. doi: 10.1001/jamanetworkopen.2021.45677.
6
Changes in spending and quality after ACO contract participation for dually eligible beneficiaries with mental illness.精神疾病双重资格受益人的 ACO 合同参与后的支出和质量变化。
Healthc (Amst). 2023 Mar;11(1):100664. doi: 10.1016/j.hjdsi.2022.100664. Epub 2022 Dec 19.
7
Association of Medicaid-Focused or Commercial Medicaid Managed Care Plan Type With Outpatient and Acute Care.医疗补助重点计划或商业医疗补助管理式医疗计划类型与门诊和急性护理的关联。
JAMA Intern Med. 2020 Dec 1;180(12):1672-1679. doi: 10.1001/jamainternmed.2020.5408.
8
Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.佛蒙特医疗补助计划中与撤销严重和持续性精神疾病预先授权豁免相关的行为健康药物的成本与使用情况。
J Manag Care Pharm. 2010 Jun;16(5):317-28. doi: 10.18553/jmcp.2010.16.5.317.
9
Associations Between a New York City Paid Sick Leave Mandate and Health Care Utilization Among Medicaid Beneficiaries in New York City and New York State.纽约市带薪病假规定与纽约市和纽约州医疗补助受益人的医疗保健利用之间的关联。
JAMA Health Forum. 2021 May 6;2(5):e210342. doi: 10.1001/jamahealthforum.2021.0342. eCollection 2021 May.
10
Association of a Care Coordination Model With Health Care Costs and Utilization: The Johns Hopkins Community Health Partnership (J-CHiP).以关怀协调模式对医疗成本和利用率的影响:约翰·霍普金斯社区卫生合作组织(J-CHiP)
JAMA Netw Open. 2018 Nov 2;1(7):e184273. doi: 10.1001/jamanetworkopen.2018.4273.

本文引用的文献

1
Adult Primary Care Physician Visits Increasingly Address Mental Health Concerns.成人初级保健医生的诊疗越来越多地涉及心理健康问题。
Health Aff (Millwood). 2023 Feb;42(2):163-171. doi: 10.1377/hlthaff.2022.00705.
2
Association of Alternative Payment and Delivery Models With Outcomes for Mental Health and Substance Use Disorders: A Systematic Review.替代支付和交付模式与精神健康和物质使用障碍结果的关联:系统评价。
JAMA Netw Open. 2020 Jul 1;3(7):e207401. doi: 10.1001/jamanetworkopen.2020.7401.
3
Access to Primary, Mental Health, and Specialty Care: a Comparison of Medicaid and Commercially Insured Populations in Oregon.
获得初级、心理健康和专科护理:俄勒冈州医疗补助计划参保人群与商业保险参保人群的比较
J Gen Intern Med. 2020 Jan;35(1):247-254. doi: 10.1007/s11606-019-05439-z. Epub 2019 Oct 28.
4
Assessing quality indicators related to mental health emergency room utilization.评估与心理健康急诊室使用情况相关的质量指标。
BMC Emerg Med. 2019 Jan 15;19(1):8. doi: 10.1186/s12873-019-0223-8.
5
Medicare Spending after 3 Years of the Medicare Shared Savings Program.医疗保险共享储蓄计划实施 3 年后的医疗保险支出。
N Engl J Med. 2018 Sep 20;379(12):1139-1149. doi: 10.1056/NEJMsa1803388. Epub 2018 Sep 5.
6
New York State Medicaid Reforms: Opportunities and Challenges to Improve the Health of Those with Serious Mental Illness.纽约州医疗补助改革:改善重度精神疾病患者健康状况的机遇与挑战
J Health Care Poor Underserved. 2017;28(3):839-852. doi: 10.1353/hpu.2017.0081.
7
Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia.评估初级保健作为精神分裂症患者心理健康之家的潜力。
Gen Hosp Psychiatry. 2017 Jul;47:14-19. doi: 10.1016/j.genhosppsych.2017.03.002. Epub 2017 Mar 7.
8
An Examination of New York State's Integrated Primary and Mental Health Care Services for Adults with Serious Mental Illness.对纽约州为患有严重精神疾病的成年人提供的综合初级和心理健康护理服务的考察。
Rand Health Q. 2014 Dec 30;4(3):13.
9
Oregon's Medicaid Reform And Transition To Global Budgets Were Associated With Reductions In Expenditures.俄勒冈州的医疗补助改革及向全球预算的转变与支出减少相关。
Health Aff (Millwood). 2017 Mar 1;36(3):451-459. doi: 10.1377/hlthaff.2016.1298.
10
Early Performance in Medicaid Accountable Care Organizations: A Comparison of Oregon and Colorado.医疗补助责任医疗组织的早期表现:俄勒冈州与科罗拉多州的比较
JAMA Intern Med. 2017 Apr 1;177(4):538-545. doi: 10.1001/jamainternmed.2016.9098.